ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations

Dec.05.2022
ARFNZ Criticizes Health Ministry's Latest E-Cigarette Regulations
New Zealand respiratory fund criticizes Health Department's latest outbreak regulations but advocates reducing tobacco harm instead of attacking e-cigarettes.

The latest outbreak from the Ministry of Health is disappointing, but unfortunately not surprising, according to Nancy Loucas, Executive Coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), in response to the Asthma and Respiratory Foundation NZ (ARFNZ).


She made the comment after ARFNZ claimed that the Ministry of Health had not achieved a proper balance with New Zealand's e-cigarette regulations.


ARFNZ's exaggerations and unfounded claims about e-cigarettes persist, but in reality, New Zealand has successfully implemented a harm reduction strategy for tobacco, leading to a smoke-free New Zealand by 2025. According to Ms. Loucas, ARFNZ should focus their attacks on combustible cigarettes instead.


CAPHRA was shocked to learn from the latest official statistics that ARFNZ is continuing on the path of new prohibitionism. Earlier this month, it was revealed that New Zealand's smoking rate has dropped from 9.4% of adults smoking daily a year ago to a historic low of 8%.


The Smoke-Free Environment and Regulated Products (Smoked Tobacco) Amendment is currently under parliamentary review. Its aim is to restrict the attractiveness and accessibility of cigarettes.


Ms. Lucas stated that ARFNZ should only be focusing on the Smoke-free Amendment Bill. Instead, they seem determined to continuously undermine and criticize the Ministry of Health's position on e-cigarettes. The issue here is cigarettes, not safer nicotine alternatives that save the lives of thousands of New Zealand smokers every year.


According to CAPHRA, New Zealand's smoke-free and THR policies are being studied and replicated by many other countries. Recently, a parliamentary delegation from Malaysia visited New Zealand to learn how smoking rates were halved in the past decade. New Zealand's regulatory framework is also crucial for recent regulations in the Philippines, and even Thailand is considering creating its own regulations based on New Zealand's model.


We urge the Deputy Minister of Health, Dr. Ayesha Verrall, to continue down the path of Tobacco Harm Reduction (THR), which has been successful in helping adult New Zealand smokers switch to e-cigarettes - a highly effective and harm-reducing smoking cessation tool. It is not the time to be distracted by minor issues.


We also urge ARFNZ to follow science and facts. Let's focus on the real issue - combustible tobacco," said Nancy Loucas.


2FIRSTS will continue to provide ongoing coverage of this topic, with future updates available on the 2FIRSTS app. Scan the QR code below to download the app.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
Trump Reportedly Signs Off on Plan to Fire FDA Commissioner Marty Makary
According to The Wall Street Journal, people familiar with the matter said President Trump has signed off on a plan to fire FDA Commissioner Marty Makary, though the plan is not yet final and could change. The report said Makary’s tenure has included clashes over vaping, abortion and drug policy, and that some senior administration officials view him as struggling to manage the agency.
May.09 by 2FIRSTS.ai
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands Expands Blu Fruit-Flavour Offerings Following Consumer Preference Data
Imperial Brands has announced the launch of a new Sour Berry flavour for its Blu vape range. The product will launch across retail this month, with both the Blu bar kit and Blu pod pack carrying a recommended retail price of GBP 5.99 (approximately USD 7.79, based on 1 GBP ≈ 1.30 USD).
Apr.03 by 2FIRSTS.ai
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
Fifth Circuit Hears Challenge to FDA’s Standard for Reviewing Flavored Vape Applications
A three-judge panel of the U.S. Court of Appeals for the Fifth Circuit heard oral arguments on Tuesday in a case brought by seven small vape-liquid companies challenging the Food and Drug Administration’s denial of marketing authorization for their flavored electronic nicotine products.
Apr.30 by 2FIRSTS.ai
JTI Invests EUR 300 Million in New Factory in Romania to Advance Its Localized Expansion
JTI Invests EUR 300 Million in New Factory in Romania to Advance Its Localized Expansion
After being present in Romania for more than 30 years, Japan Tobacco International (JTI) announced that it will invest approximately EUR 300 million (about USD 324 million) to build a green, state-of-the-art new factory in Ilfov County, Romania, reinforcing its long-term commitment to the country.
Mar.31 by 2FIRSTS.ai
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
U.S. International Trade Commission has refused to pause the import and sales bans imposed on cannabis vape company Stiiizy while it appeals the agency’s patent infringement ruling in its dispute with Pax Labs.
Apr.07 by 2FIRSTS.ai
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters Exclusive: FDA’s Fast-Track Review of Nicotine Pouches Slows Over Youth and New-User Concerns
Reuters reported on April 1 that several popular nicotine pouch products still have not been cleared for sale in the United States despite a fast-track review pilot run by the U.S. Food and Drug Administration. Three sources said FDA reviewers have taken a cautious approach because of potential risks to youth and other non-tobacco users, including the possibility of driving nicotine addiction among adults who do not already smoke.
Apr.02 by 2FIRSTS.ai